Skip to main content
Clinical Trials/NCT06335095
NCT06335095
Recruiting
N/A

Gait Analysis and Degenerative Spine

Universidade Nova de Lisboa1 site in 1 country200 target enrollmentApril 1, 2024
ConditionsSpinal Disease

Overview

Phase
N/A
Intervention
Not specified
Conditions
Spinal Disease
Sponsor
Universidade Nova de Lisboa
Enrollment
200
Locations
1
Primary Endpoint
Change from baseline in gait parameter - step length (m) - at 3 months
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this observational study is to analyse the biomechanics of a degenerative spinal disease. The main questions it aims to answer are:

  • What are the biomechanical variables affected by the disease
  • How they evolve with disease progression and treatment
Registry
clinicaltrials.gov
Start Date
April 1, 2024
End Date
September 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age between 50 and 85 years
  • Diagnosis of spinal disease by clinical and imagiological criteria
  • More than 3 months duration of disease
  • Ability to give consent
  • Fluent portuguese speaker

Exclusion Criteria

  • Previous spine surgery
  • Spinal instability
  • Neurological disease that might interfere with walking
  • Known orthopedic conditions that causes significant gait impairment
  • Dementia or development disorder with cognitive impairment
  • Inability to give consent

Outcomes

Primary Outcomes

Change from baseline in gait parameter - step length (m) - at 3 months

Time Frame: 3 months

The change will be defined by a 10% increase in step length (meters) at 3 months from baseline assessment.

Change from baseline in gait parameter - step length (m) - at 12 months

Time Frame: 12 months

The change will be defined by a 10% increase in step length (meters) at 12 months from baseline assessment.

Change from baseline in gait parameter - speed (m/s) - at 3 months

Time Frame: 3 months

The change will be defined by a 10% increase in speed (meters/second) at 3 months from baseline assessment.

Change from baseline in gait parameter - step length (m) - at 6 months

Time Frame: 6 months

The change will be defined by a 10% increase in step length (meters) at 6 months from baseline assessment.

Change from baseline in gait parameter - speed (m/s) - at 6 months

Time Frame: 6 months

The change will be defined by a 10% increase in speed (meters/second) at 6 months from baseline assessment.

Change from baseline in gait parameter - speed (m/s) - at 12 months

Time Frame: 12 months

The change will be defined by a 10% increase in speed (meters/second) at 12 months from baseline assessment.

Change from baseline in gait parameter - step width (m) - at 3 months

Time Frame: 3 months

The change will be defined by a 10% decrease in step width (meters) at 3 months from baseline assessment.

Change from baseline in gait parameter - step width (m) - at 6 months

Time Frame: 6 months

The change will be defined by a 10% decrease in step width (meters) at 6 months from baseline assessment.

Change from baseline in gait parameter - step width (m) - at 12 months

Time Frame: 12 months

The change will be defined by a 10% decrease in step width (meters) at 12 months from baseline assessment.

Secondary Outcomes

  • Change from baseline in Back Pain as measured by the Numeric Pain Rating Scale (NPRS) at 6 months(6 months)
  • Change from baseline in disability as measured by the Oswestry Disability Index (ODI) at 6 months(6 months)
  • Change from baseline in disability as measured by the Core Outcome Measures Index (COMI) at 6 months(6 months)
  • Change from baseline in Quality of Life as measured by the European Quality of Life-5 Dimensions Questionnaire (EQ-5D) at 3 months(3 months)
  • Change from baseline in disability as measured by the Core Outcome Measures Index (COMI) at 12 months(12 months)
  • Change from baseline in Back Pain as measured by the Numeric Pain Rating Scale (NPRS) at 3 months(3 months)
  • Change from baseline in disability as measured by the Oswestry Disability Index (ODI) at 12 months(12 months)
  • Change from baseline in Quality of Life as measured by the European Quality of Life-5 Dimensions Questionnaire (EQ-5D) at 12 months(12 months)
  • Change from baseline in disability as measured by the Core Outcome Measures Index (COMI) at 3 months(3 months)
  • Change from baseline in Back Pain as measured by the Numeric Pain Rating Scale (NPRS) at 12 months(12 months)
  • Change from baseline in Quality of Life as measured by the European Quality of Life-5 Dimensions Questionnaire (EQ-5D) at 6 months(6 months)
  • Change from baseline in disability as measured by the Oswestry Disability Index (ODI) at 3 months(3 months)

Study Sites (1)

Loading locations...

Similar Trials